tradingkey.logo

Phibro Animal Health Corp

PAHC
View Detailed Chart
53.070USD
+3.070+6.14%
Close 02/06, 16:00ETQuotes delayed by 15 min
2.15BMarket Cap
23.36P/E TTM

Phibro Animal Health Corp

53.070
+3.070+6.14%
Intraday
1m
30m
1h
D
W
M
D

Today

+6.14%

5 Days

+32.18%

1 Month

+34.22%

6 Months

+100.34%

Year to Date

+42.05%

1 Year

+115.91%

View Detailed Chart

Key Insights

Phibro Animal Health Corp's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 33 out of 159 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 44.00.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Phibro Animal Health Corp's Score

Industry at a Glance

Industry Ranking
33 / 159
Overall Ranking
97 / 4521
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive

Phibro Animal Health Corp Highlights

StrengthsRisks
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 32.55% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.30B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 40.30%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 40.30%.
Fairly Valued
The company’s latest PE is 23.36, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 20.20M shares, decreasing 15.33% quarter-over-quarter.
Held by Paul Tudor Jones
Star Investor Paul Tudor Jones holds 10.18K shares of this stock.

Analyst Rating

Based on 4 analysts
Hold
Current Rating
44.000
Target Price
-12.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Phibro Animal Health Corp News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Phibro Animal Health Corp Info

Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
Ticker SymbolPAHC
CompanyPhibro Animal Health Corp
CEOBendheim (Jack C)
Websitehttps://www.pahc.com/
KeyAI